Understanding how liver cancer develops through specific signaling pathways

Signaling pathways during hepatocarcinogenesis

NIH-funded research University of Hawaii at Manoa · NIH-10775793

This study is looking at how certain proteins in the body affect the growth of liver cancer, hoping to find new ways to treat it that could help patients in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Hawaii at Manoa NIH-funded
Lab location1 site (Honolulu, United States)
Project IDNIH-10775793 on NIH RePORTER

What this research studies

This research investigates the complex signaling pathways involved in the development of hepatocellular carcinoma (HCC), a serious type of liver cancer. The study focuses on the roles of two protein complexes, mTORC1 and mTORC2, in regulating cell growth and metabolism, particularly how they interact with key proteins that may influence cancer progression. By using mouse models, researchers aim to uncover how these pathways contribute to liver tumor formation and identify potential targets for new treatments. Patients may benefit from insights gained that could lead to improved therapies for HCC.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with hepatocellular carcinoma or those at high risk for developing liver cancer.

Not a fit: Patients with other types of cancer or those without liver disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies for patients with hepatocellular carcinoma.

How similar studies have performed: Previous research has shown promising results in understanding signaling pathways in various cancers, suggesting that this approach could yield valuable insights for hepatocellular carcinoma as well.

Where this research is happening

Honolulu, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancersneoplasm/cancerDisorderDisease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.